For more details on our speakers and chairs, visit the Speakers page.

9.00 

Official opening

Dr Mairéad O'Driscoll, Chief Executive, Health Research Board

9.20 - 11.00

Session 1: The promise of personalised medicine

Personalised medicine promises to transform the way healthcare is delivered. This session will set the scene with an overview of what personalised medicine is and the opportunities it offers.

Chair: Prof. Bernie Hannigan, Chairperson, HRB Board

09.20: Prof. Dame Anna Dominiczak, University of Glasgow

10.00: Ejner Moltzen, ICPerMed
 

11.00 - 12.00

Session 2: Personalised medicine in action

This session will present case studies showcasing the potential of personalised medicine across a range of applications.

Chair: Prof. Aedín Culhane, University of Limerick School of Medicine

11.00: Case studies, with speakers including: 

- Prof. Norman Delanty, Beaumont Hospital/Royal College of Surgeons Ireland
- Prof. Maeve Lowery, Trinity College Dublin/St James's Hospital

12.00 - 13.00

Session 3: Value assessment, cost and equity in personalised medicine

How should we define value when it comes to implementing personalised medicine? This session will broaden out the debate to examine some of the challenges in areas such as cost and equity.

Chair: Prof. Charles Normand, Trinity College Dublin

12.00: Prof. Katherine Payne, University of Manchester

12.20: Prof. Michael Barry, National Centre of Pharmacoeconomics 

14.15 - 16.00

Session 4: Perspectives on the path forward for personalised medicine

The final session will bring together aspects from across the day's discussions to look ahead to the future - asking how stakeholders across health and research can work together to make the promise of personalised medicine a reality in Ireland. 

Chair: Muiris O'Connor, Department of Health

14.15 Discussion panel, with contributors including:

- Deirdre Poretti, Roche

- Dr Aisling de Paor, Dublin City University

- Dr Teresa Maguire, Health Research Board

More details and speakers to follow - watch this space or follow us on Twitter and LinkedIn for the latest updates!